Deutsche Bank is fond of its Health Management (NYSE:HMA) takeout thesis (previous) and now says...

Deutsche Bank is fond of its Health Management (NYSE:HMA) takeout thesis (previous) and now says "recent management turnover" and the activist agenda of the company's largest shareholder (Glenview, 13D filing) "significantly increase the probabilities HMA's board could put the company in play." $20/share seems like a reasonable figure to DB and based on analyst Darren Lehrich's recent note, Tenet (NYSE:THC) could be the bidder. HMA upgraded to Buy (PT to $18 from $12). Shares +11.27% premarket.